Flemming Winther Bach

Flemming Winther Bach serves as Overlæge (Senior Physician) at Aalborg University Hospital within the Faculty of Medicine's Department of Neurology. With an extensive publication record spanning over two decades, he has established himself as a prominent researcher in stroke, migraine, and neuropathic pain disorders. His clinical and research work bridges the gap between neurological practice and academic medicine at one of Denmark's leading medical institutions.

Dr. Bach's primary research interests focus on cerebrovascular diseases, particularly ischemic and hemorrhagic stroke mechanisms and prevention strategies. His work extensively examines the relationship between dietary factors (especially fatty acids) and stroke risk, as well as genetic factors in migraine and epilepsy. Additional research areas include whiplash-associated disorders, neuropathic pain mechanisms, and the clinical applications of medical cannabis. His research fingerprint prominently features Whiplash Injury (100%), Neuropathic Pain (44%), Brain Ischemia (44%), and Polyneuropathy (42%), indicating his specialization in these neurological domains.

Analysis of his 98 publications reveals a consistent trajectory of high-impact research in neurology, with particular emphasis on stroke epidemiology and treatment. His recent work (2020-2025) shows increasing focus on genetic aspects of neurological disorders and refined approaches to stroke prevention. The 2025 publication on migraine genetics represents a significant expansion into neurogenetics, while his stroke-related publications maintain strong methodological rigor with large Danish cohort studies.

Dr. Bach actively participates in the scientific community through conference presentations and professional memberships. He has participated in significant events including the 8th International Conference on the Mechanisms and Treatment of Neuropathic Pain (2005), the 12th Congress of the International Headache Society (2005), and Expanding Vistas in Neuropathic Pain (2005). He maintains active memberships in both the Dansk Hovedpineselskab (Danish Headache Society) since 2005 and the Scandinavian Association for the Study of Pain since 2003.

His media engagement demonstrates commitment to public discourse on neurological health issues, particularly his 2017 commentary on medical cannabis, which received significant media attention across multiple platforms including news outlets, social media, and policy discussions. This public engagement complements his substantial scholarly contributions to the field of neurology.